Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
PR02 - Press Conference
- 09:45 - 10:30
- 9/08/2019
- Location: CC7.1 A&B
- Type: Press Conference
- Track: Immuno-oncology
-
+
PR02.04 - Mutations Associated with Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis from the MYSTIC Trial
10:02 - 10:09 | Presenter: Naiyer A Rizvi
- Abstract
No abstract available for this presentation
-
+
MS01 - Immunotherapy Resistance
- 10:30 - 12:00
- 9/08/2019
- Location: San Francisco (2009)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Immuno-oncology
- Moderators:Ignacio Gil-Bazo, Nuria Viñolas
-
+
MS01.02 - Treatment Determining Markers - What Have We Achieved so Far?
10:45 - 11:00 | Presenter: Naiyer A Rizvi
- Abstract
Loading...
-
+
IS09 - Symposium by Physicians' Education Resource, LLC (PER): Leveraging The Lung Cancer Team In Stage III NSCLC With Immuno-Oncology Strategies (Not IASLC CME Accredited)
- 12:00 - 13:30
- 9/08/2019
- Location: Barcelona (2005)
- Type: Industry Symposia & Workshops
- Track:
-
+
OA03 - Systemic Therapies for SCLC: Novel Targets and Patients' Selection
- 13:30 - 15:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Christine Lee Hann, Makoto Nishio
-
+
OA03.07 - Immune-Related Adverse Events and Clinical Outcome to Anti PD-1 Axis Inhibition in SCLC: A Multicenter Retrospective Analysis
14:35 - 14:45 | Presenter: Biagio Ricciuti | Author(s): abdul rafeh Naqash, Brian Henick, Deepa Rangachari, Jarushka Naidoo, Deepti Venkatraman, Giuseppe Lamberti, Gonzalo Recondo Jr., Jiajia Zhang, Shravanti Macherla, Sameer Baig, Paul Raymond Walker, Kartik Sehgal, Renato Umeton, Lynette M Sholl, Naiyer A Rizvi, Daniel B Costa, Mark Awad
- Abstract
Loading...
-
+
YI04 - Basics of Immunology
- 13:30 - 15:00
- 9/08/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Young Investigator Session
- Track: Young Investigators
- Moderators:Noemi Reguart, Julie R Brahmer
-
+
YI04.04 - How to Select Patients for Immunotherapy
14:30 - 14:50 | Presenter: Naiyer A Rizvi
- Abstract
Loading...
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.07 - Mutations Associated with Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis from the MYSTIC Trial
16:20 - 16:30 | Presenter: Naiyer A Rizvi | Author(s): Byoung Chul Cho, Niels Reinmuth, Ki Hyeong Lee, Alexander Luft, Myung-Ju Ahn, Vassiliki A Papadimitrakopoulou, John Victor Heymach, Urban Scheuring, Brandon Higgs, Jiabu Ye, Michael Kuziora, Song Wu, Feng Liu, Han Si, Solange Peters
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.11 - STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
15:10 - 15:15 | Presenter: John Victor Heymach | Author(s): Ferdinandos Skoulidis, Kathryn C. Arbour, Matthew Hellmann, Pradnya Dinkar Patil, Melina E Marmarelis, Dwight Hall Owen, Mark Awad, Joseph C. Murray, Benjamin Philip Levy, Jessica Hellyer, Justin F. Gainor, Tyler Stewart, Sarah B. Goldberg, Anastasios Dimou, Christine M Bestvina, Amy Lauren Cummings, Yasir Elamin, Vincent Lam, Jianjun Zhang, Catherine Shu, Jonathan Wesley Riess, Collin M Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Adrian G Sacher, Matthias Scheffler, Biagio Ricciuti, Deepti Venkatraman, Hira Rizvi, Corinne Liu, Rocio Perez Johnston, Ying Ni, Joseph Azok, Melanie Wain Kier, Sharyn I Katz, Kurtis D. Davies, Jeremy P Segal, Lauren Ritterhouse, Hiram Shaish, LUDOVIC Lacroix, Regan Memmott, John R Madrigal, Jonathan Goldman, Sally CM Lau, Jonathan Killam, Zenta Walther, Brett Carter, Mark Woodcock, Jack Roth, Stephen Swisher, Natasha B Leighl, Subba Digumarthy, Meghan Mooradian, Julia Rotow, Juergen Wolf, Giorgio Vittorio Scagliotti, David Planchard, Benjamin Besse, Trever G Bivona, David R Gandara, Edward Garon, Naiyer A Rizvi, D. Ross Camidge, Kurt A Schalper, Roy S. Herbst, Alice T. Shaw, Joel W Neal, Heather A Wakelee, Julie R Brahmer, Pasi A Jänne, David P Carbone, Charu Aggarwal, Nathan Pennell, Charles M Rudin, Vassiliki A Papadimitrakopoulou
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-01 - Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 ≥50%
10:15 - 10:15 | Presenter: Sue Lee | Author(s): Ahmet Sezer, Miranda Gogishvili, Dmitry Bentsion, Saadettin Kilickap, Anna Lowczak, Mahmut Gumus, Oleg Gladkov, Philip Clingan, Virote Sriuranpong, Naiyer A Rizvi, Siyu Li, Pamela Snodgrass, Mark Navarro, Israel Lowy, Petra Rietschel
- Abstract
Loading... -
+
P2.01-07 - Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1-Containing Therapy (HUDSON)
10:15 - 10:15 | Presenter: Si-Houy Lao-Sirieix | Author(s): John Victor Heymach, Patrick M. Forde, Michael Thomas, Keunchil Park, Benjamin Besse, Mark Awad, Glenwood D. Goss, Naiyer A Rizvi, Helen A Ambrose, Wouter Hanekom, Steven Fox, Philip J Jewsbury, Gayle P Pouliot, Peter G Mortimer, Sabina I Patel, Kris Sachsenmeier, J.C Barrett, M Stuart, Z Szucs, L Walton
- Abstract
Loading...